Latest Breaking News On - Davidj massop - Page 1 : comparemela.com

Presented at ASRS 2023, an analysis of the Portal trial suggests the efficacy and safety of PDS with ranibizumab was maintained over 5 years in patients with nAMD.

United statesDavidj massopGenentech rocheDrug administrationAmerican society of retina specialistsAmerican societyRetina specialistsAnnual meetingWolfe eye clinic